Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Seeger

Showing results (171-180 of 266) with videos related to

Pageof 27
Sort By:
Cancer|November 19, 2004
Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis indexChie Kobayashi, Hector L Monforte-Munoz, Robert B Gerbing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Parental smoking and alcohol consumption and risk of neuroblastomaQ Yang, A F Olshan, M L Bondy, et al.
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer GroupR Cooper, Y Khakoo, K K Matthay, et al.
Cancer|September 24, 2004
TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevanceHiroyuki Shimada, Atsuko Nakagawa, Julius Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2013
Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapyYin Liu, Hong-Wei Wu, Michael A Sheard, et al.
Cancer Research|January 2, 2009
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cellsTasnim Ara, Liping Song, Hiroyuki Shimada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumorsM F Ozkaynak, K Matthay, M Cairo, et al.
Cancer Research|February 17, 2000
Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramideA Erdreich-Epstein, H Shimada, S Groshen, et al.
Cancer|December 18, 2001
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer GroupS Goto, S Umehara, R B Gerbing, et al.
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group StudyE Rudnick, Y Khakoo, N L Antunes, et al.
Pageof 27

Showing results (171-180 of 266) with videos related to

Sort By:
Pageof 27
Cancer|November 19, 2004
Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis indexChie Kobayashi, Hector L Monforte-Munoz, Robert B Gerbing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Parental smoking and alcohol consumption and risk of neuroblastomaQ Yang, A F Olshan, M L Bondy, et al.
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer GroupR Cooper, Y Khakoo, K K Matthay, et al.
Cancer|September 24, 2004
TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevanceHiroyuki Shimada, Atsuko Nakagawa, Julius Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2013
Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapyYin Liu, Hong-Wei Wu, Michael A Sheard, et al.
Cancer Research|January 2, 2009
Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cellsTasnim Ara, Liping Song, Hiroyuki Shimada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumorsM F Ozkaynak, K Matthay, M Cairo, et al.
Cancer Research|February 17, 2000
Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramideA Erdreich-Epstein, H Shimada, S Groshen, et al.
Cancer|December 18, 2001
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer GroupS Goto, S Umehara, R B Gerbing, et al.
Medical and Pediatric Oncology|May 10, 2001
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group StudyE Rudnick, Y Khakoo, N L Antunes, et al.
Pageof 27